S. Wack

发表

Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes

J. Marescaux, A. Hajri, J. Lehn, 2004, Cancer Gene Therapy.

K‐ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment

A. Hajri, S. Wack, M. Aprahamian, 2007, Cancer science.

Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine.

Sophie J Deharvengt, A. Hajri, S. Wack, 2007, International journal of oncology.

Transcriptional tumor‐selective promoter targeting of E. coli purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy

Sophie J Deharvengt, A. Hajri, S. Wack, 2005, The journal of gene medicine.

Suicide Gene/Prodrug Therapy for Pancreatic Adenocarcinoma by E. Coli Purine Nucleoside Phosphorylase and 6-Methylpurine 2′-deoxyriboside

Sophie J Deharvengt, A. Hajri, S. Wack, 2004, Pancreas.

Squalenoyl Gemcitabine Monophosphate: Synthesis, Characterisation of Nanoassemblies and Biological Evaluation

P. Couvreur, S. Wack, E. Lepeltier, 2011 .

In Vitro and In Vivo Efficacy of Photofrin® and Pheophorbide a, a Bacteriochlorin, in Photodynamic Therapy of Colonic Cancer Cells¶

A. Hajri, S. Wack, M. Aprahamian, 2002, Photochemistry and photobiology.

Feasibility, sensitivity, and reliability of laser-induced fluorescence imaging of green fluorescent protein-expressing tumors in vivo.

Maurice Whelan, Jacques Marescaux, Francine Heisel, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

In Vitro and In Vivo Efficacy of Photofrin® and Pheophorbide a, a Bacteriochlorin, in Photodynamic Therapy of Colonic Cancer Cells ¶

A. Hajri, S. Wack, M. Aprahamian, 2002 .

Squalenoyl nucleoside monophosphate nanoassemblies: new prodrug strategy for the delivery of nucleotide analogues.

P. Couvreur, S. Wack, D. Desmaële, 2010, Bioorganic & medicinal chemistry letters.

Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes.

P. Couvreur, F. Meneau, S. Wack, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Improving the Antitumor Activity of Squalenoyl‐Paclitaxel Conjugate Nanoassemblies by Manipulating the Linker between Paclitaxel and Squalene

P. Couvreur, S. Wack, A. Maksimenko, 2013, Advanced healthcare materials.

Dual Effect of Laparoscopy on Cell-Mediated Immunity

J. Marescaux, D. Mutter, S. Wack, 2000, European Surgical Research.

Design, optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochloride.

J. Benoit, S. Wack, P. Saulnier, 2012, International journal of pharmaceutics.

A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity

P. Couvreur, F. Dosio, L. Cattel, 2014, Proceedings of the National Academy of Sciences.

Telomerase transcriptional targeting of inducible Bax/TRAIL gene therapy improves gemcitabine treatment of pancreatic cancer.

A. Hajri, S. Wack, M. Aprahamian, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Valproic acid induces non-apoptotic cell death mechanisms in multiple myeloma cell lines.

G. Berchem, S. Wack, N. Brons, 2007, International journal of oncology.